Published in Cancer Weekly, November 15th, 2005
According to a study from Rhode Island, "This was a prospective, randomized, controlled clinical trial assessing the safety and efficacy of a living bilayered skin construct (BSC; Organogenesis, Canton, MA) in treating full-thickness surgical excision wounds. We enrolled 31 patients needing excision of a nonmelanoma skin cancer."
K.G. Donohue and colleagues, Roger Williams Medical Center, explained "The patients consisted of 18 females and 13 males, with an average age of 67 years (range: 44 to 84 years)....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.